Patient Research
Find a studySpecialtiesConditionsTreatmentsBy countryLearn
Sign in
All treatments
Treatment

All participants receive standard Dabrafenib+Trametinib, either taken continuously every day (continuous arm), or with p clinical trials

1 indexed studies · 0 currently recruiting

  • Completed

    A research study to compare treatment with dabrafenib and trametinib, either taken continuously every day, or intermittently (with planned treatment breaks in each cycle), in patients with metastatic Melanoma

    This study tests two ways of giving targeted tablets (dabrafenib and trametinib) for advanced melanoma with a BRAF gene change. Researchers want to find out if taking planned breaks from treatment works as well as taking the tablets every single day, while possibly causing fewer side effects.

    For: Melanoma
    United Kingdom · England · Scotland
Advertisement
Advertisement
Advertisement
Patient.info Research

Find clinical research studies and trials explained in plain English - powered by Patient.info.

About
  • About us
  • Advertise with us
  • Partnerships
  • Authors
  • Contact us
Research explained
  • What is a clinical trial?
  • Trial phases explained
  • Why volunteer?
  • Clinical research FAQ
  • All health-research articles
Legal
  • About our content
  • Report a correction
  • Accessibility statement
  • Cookie policy
  • Privacy policy
  • Terms of use
  • Editorial policy
Find a study

Search clinical research studies and trials by condition, location and eligibility.

Browse studies →Learn about trials →
Information only. Research.Patient.info surfaces public clinical-trial registry data and explains it in plain English. We are not affiliated with the MHRA, HRA, NHS, NIHR or any regulator. Inclusion of a study is not an endorsement and is not medical advice — always discuss with your own doctor before agreeing to take part. See about our content or report a correction.
© 2026 Navigate Health Ltd. All rights reserved.
Registered number: 16229589
Registered office: 128 City Road, London, United Kingdom, EC1V 2NX.
Patient is a UK registered trade mark.
Patient does not provide medical advice, diagnosis or treatment.